AngioDynamics ANGO Net additions (releases) charged to costs and expenses
Net additions (releases) charged to costs and expenses at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's net additions (releases) charged to costs and expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's net additions (releases) charged to costs and expenses?
- AngioDynamics (ANGO) reported net additions (releases) charged to costs and expenses of $317K in Q4 2025.
- How has AngioDynamics's net additions (releases) charged to costs and expenses changed year-over-year?
- AngioDynamics's net additions (releases) charged to costs and expenses increased by 123.2% year-over-year, from $142K to $317K.
- What is the long-term trend for AngioDynamics's net additions (releases) charged to costs and expenses?
- Over 3 years (2022 to 2025), AngioDynamics's net additions (releases) charged to costs and expenses has grown at a 80.9% compound annual growth rate (CAGR), from $118K to $699K.